Health Innovation Yorkshire & Humber are hosting a workshop in Leeds today to discuss the optimal use case for PinPoint in the Lower GI urgent suspected cancer pathway. Clinicians, service managers and patient representatives will be joining us from regions across England to hear about our latest data and proposed utility for suspected bowel cancer patients.
We will be joined by Cancer Research UK Director of Evidence & Implementation, Naser Turabi, who will deliver opening remarks.
